The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

An­oth­er fire breaks out at a No­vo Nordisk site; Ther­mo Fish­er ear­marks $58M in­to a new lab

11 months ago

Cor­rect­ed: Emer­gent sells Bal­ti­more fa­cil­i­ty for $30M

11 months ago
Pharma

Sam­sung Bio and Bax­ter di­al up man­u­fac­tur­ing deal to $223M

11 months ago
Deals

Hik­ma to take over sev­er­al as­sets from Xel­lia, in­clud­ing a US man­u­fac­tur­ing site

11 months ago
Deals

J&J ce­ments foot­print in Italy with €580M in in­vest­ments over the next 5 years

11 months ago
R&D
Pharma

Alchem faces fines over price-fix­ing al­le­ga­tion from the Eu­ro­pean Com­mis­sion

11 months ago
Pharma

Ra­dio­phar­ma ex­ecs warn that lutetium could be at risk of short­age 

11 months ago

Siegfried nabs US site from Cu­ria; Mer­ck KGaA pumps €62M more in­to its head­quar­ters

11 months ago

Cor­rect­ed: Life sci­ence com­pa­ny Ag­i­lent cuts over 180+ em­ploy­ees in Cal­i­for­nia 

11 months ago
People

Ky­owa Kirin in­vests $530M in first man­u­fac­tur­ing site in North Amer­i­ca

11 months ago
R&D

Mer­ck KGaA’s South Ko­re­an part­ner­ship; Sanofi’s sup­ply chain al­liance with DHL

11 months ago

Ger­man ra­dio­phar­ma nabs €188M to boost iso­tope man­u­fac­tur­ing, ad­vance can­cer pipeline

11 months ago
Financing

FDA hands Chi­nese drug man­u­fac­tur­er a Form 483 not­ing em­ploy­ees de­stroyed doc­u­ments 

11 months ago
China
FDA+

AI is un­like­ly to take off among CD­MOs at the same scale as bio­phar­ma com­pa­nies, in­sid­ers say

11 months ago
AI

Rayze­Bio warned of po­ten­tial iso­tope sup­ply is­sues be­fore BMS deal

11 months ago
R&D

Ex­clu­sive: Iso­tope short­age forces pause of Bris­tol My­ers Phase 3 ra­dio­phar­ma­ceu­ti­cal tri­al

11 months ago
R&D
Pharma

Adap­ti­m­mune taps Gala­pa­gos to de­cen­tral­ize man­u­fac­tur­ing of sol­id tu­mor T cell ther­a­py

12 months ago
Deals
Cell/Gene Tx

FDA to be­gin re­struc­tur­ing its in­spec­tion of­fice in Oc­to­ber

12 months ago
FDA+

Al­mac’s 2023 rev­enue bump; France to in­vest in eas­ing green­house gas im­pact

12 months ago

Ori Biotech, Cy­ti­va sep­a­rate­ly un­veil tech to ac­cel­er­ate cell ther­a­py pro­duc­tion

12 months ago
Cell/Gene Tx

GLP-1 pre­scrip­tions reach all-time high as Lil­ly and No­vo scram­ble to keep pace with de­mand

Last year
Pharma

Lil­ly bud­gets ad­di­tion­al $5.3B for tirzepatide API fac­to­ry in In­di­ana

Last year

Chi­nese CD­MO takes over Pfiz­er’s UK fa­cil­i­ty; Serum In­sti­tute ships malar­ia vac­cine to Africa

Last year

Mer­ck KGaA makes $600M bet to boost man­u­fac­tur­ing for vi­ral vec­tors

Last year
Deals
Cell/Gene Tx
First page Previous page 11121314151617 Next page Last page
A service from the Financial Times